Boehringer Ingelheim, the UK ethical pharmaceutical manufacturers, has confirmed that it is in the process of shortlisting investment managers for its £80m defined benefit pension scheme.
Pensions administrator, Jean Taylor, said that a decision to review the investment strategy was made last June to assess whether current arrangements were “still applicable to the scheme”. The s...
To continue reading this article...
Join Professional Pensions
Become a Professional Pensions Lite Member today
In just a few clicks you can start your free Professional Pensions Lite membership for 12 months, providing you access to:
- Three complimentary articles per month covering the latest real-time news, analysis and opinion from the industry
- Receive important and breaking news stories via our two daily news alerts
- Hear from industry experts and other forward-thinking leaders
Are you a trustee, investment consultant or in-house pension and benefit scheme professional? You can apply for full complimentary access here
